Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor
Conditions
Keywords
exercise, aromatase inhibitor, musculoskeletal associated symptoms, ิbreast cancer
Brief summary
A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients
Interventions
BEHAVIORALtailored exercise
tailored suitable exercise to individuals recommended for the aim of aerobic exercise at 150 minutes per week and strengthening exercise twice a week
Sponsors
Mahidol University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks * able to read and write
Exclusion criteria
* chronic arthritis * history of heart failure or acute coronary syndrome within 6 months * individuals who exercises regularly more than 150 minutes/week
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Aromatase inhibitor associated musculoskeletal symptoms (AIMSS) | 12 months | occurrence of AIMSS |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| worsening pain | 12 months | reduce numerical scale of pain more than 2 points |
| body weight | 12 months | body weight change |
| quality of life FACT-ES | 12 months | FACT-ES score |
Countries
Thailand
Contacts
CONTACTSuthinee Ithimakin, M.D
Outcome results
None listed